Browsed by
Tag: Clinical Trial

Long-Term Efficacy of Psilocybin-Assisted Psychotherapy for Cancer-Related Depression: A Two-Year Follow-Up Study

Long-Term Efficacy of Psilocybin-Assisted Psychotherapy for Cancer-Related Depression: A Two-Year Follow-Up Study

Long-Term Efficacy of Psilocybin-Assisted Psychotherapy for Cancer-Related Depression: A Two-Year Follow-Up Study A recent phase 2 clinical trial published in Cancer offers compelling evidence regarding the long-term efficacy of psilocybin-assisted psychotherapy in treating major depressive disorder (MDD) among cancer patients. The study, conducted by researchers at Sunstone Therapies and colleagues, followed 30 participants with cancer and MDD for two years after a single dose of psilocybin combined with psychological support. The results demonstrate significant and sustained improvements in both depression…

Read More Read More

Psilocybin Therapy: A Promising Novel Treatment for Depression in Cancer Patients

Psilocybin Therapy: A Promising Novel Treatment for Depression in Cancer Patients

Psilocybin Therapy: A Promising Novel Treatment for Depression in Cancer Patients Cancer significantly impacts patients’ mental health, with depression being a prevalent comorbidity. Traditional antidepressants often fall short in providing adequate relief for this population. A recent phase 2 clinical trial, published in the journal CANCER, offers a beacon of hope with promising results using psilocybin, a psychedelic compound found in certain mushrooms. The study, conducted by Sunstone Therapies and detailed in Wiley Online’s CANCER journal, investigated the safety, feasibility,…

Read More Read More